453
Views
17
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

The Effect of Vitamin D Supplementation on Glycemic Control and Lipid Profile in Patients with Type 2 Diabetes Mellitus

, MD, , MD & , MD
Pages 399-404 | Received 04 Aug 2014, Accepted 03 Mar 2015, Published online: 21 Sep 2015

REFERENCES

  • Forouhi NG, Luan J, Cooper A, Boucher BJ, Wareham NJ: Baseline serum 25-hydroxy vitamin D is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990–2000. Diabetes 57:2619–2625, 2008.
  • Forouhi NG, Ye Z, Rickard AP, Khaw KT, Luben R, Langenberg C, Wareham NJ: Circulating 25-hydroxyvitamin D concentration and the risk of type 2 diabetes: results from the European Prospective Investigation into Cancer (EPIC)-Norfolk cohort and updated meta-analysis of prospective studies. Diabetologia 55:2173–2182, 2012.
  • Akin F, Ayça B, Köse N, Duran M, Sari M, Uysal OK, Karakukcu C, Arinc H, Covic A, Goldsmith D, Okçün B, Kanbay M: Serum vitamin D levels are independently associated with severity of coronary artery disease. J Investig Med 60:869–873, 2012.
  • Yingying S, Ling Y: Can vitamin D intake assist in improving the outcome of endodontic treatment for diabetic patients. Med Hypotheses 2:1–6, 2009.
  • Foss YJ: Vitamin D deficiency is the cause of common obesity. Med Hypotheses 72:314–321, 2009.
  • Pittas A, Nelson J, Mitri J, Hillmann W, Garganta C, Nathan DM, Hu FB, Dawson-Hughess B, and the Diabetes Prevention Program Research Group: Plasma 25-hydroxyvitamin D and progression to diabetes in patients at risk for diabetes: an ancillary analysis in the Diabetes Prevention Program. Diabetes Care 35:565–573, 2012.
  • Mattila C, Knekt P, Männistö S, Rissanen H, Laaksonen MA, Montonen J, Reunanen A: Serum 25-hydroxyvitamin D concentration and subsequent risk of type 2 diabetes. Diabetes Care 30:2569–2570, 2007.
  • Bland R, Markovic D, Hills CE, Hughes SV, Chan SL, Squires PE, Hewison M: Expression of 25-hydroxyvitamin D3-1α-hydroxylase in pancreatic islets. J Steroid Biochem Mol Biol 89–90:121–125, 2004.
  • Maestro B, Davila N, Carranza MC, Calle C: Identification of a vitamin D response element in the human insulin receptor gene promoter. J Steroid Biochem Mol Biol 84:223–230, 2003.
  • Maestro B, Molero S, Bajo S: Transcriptional activation of the human insulin receptor gene by 1,25-dihydroxyvitamin D3. Cell Biochem Funct 20:227–232, 2002.
  • Schuch N, Garcia V, Vívolo S, Martini L: Relationship between vitamin D receptor gene polymorphisms and the components of metabolic syndrome. Nutr J 12:96, 2013.
  • Dunlop TW, Vaisanen S, Frank C, Molnar F, Sinkkonen L, Carlberg C: The human peroxisome proliferator-activated receptor δ gene is a primary target of 1α, 25-dihydroxyvitamin D3 and its nuclear receptor. J Mol Biol 349:248–260, 2005.
  • Cohen-Lahav M, Douvdevani A, Chaimovitz C, Shany S: The anti inflammatory activity of 1,25 dihydroxy vitamin D3 in macrophages. J Steroid Biochem Mol Biol 103:558–562, 2007.
  • Tanaka Y, Seino Y, Ishida M: Effects of vitamin D3 on the pancreatic secretion of insulin and somatostatin. Acta Endocrinol 105:528–533, 1984.
  • Chertow BS, Sivitz WI, Baranetsky NG, Clark SA, Waite A: Cellular mechanisms of insulin release: the effects of vitamin D deficiency and repletion on rat insulin secretion. Endocrinology 113:1511–1518, 1983.
  • Wang H, Xia N, Yang Y, Peng DQ: Influence of vitamin D supplementation on plasma lipid profiles: a meta-analysis of randomized controlled trials. Lipids Health Dis 11:42, 2012.
  • Mithal A, Wahl DA, Bonjour JP, Burckhardt P, Dawson-Hughes B, Eisman JA,El-Hajj Fuleihan G, Josse RG, Lips P, Morales-Torres J, and the IOF Committee of Scientific Advisors (CSA) Nutrition Working Group: Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int 20:1807–1820, 2009.
  • Tacher T, Clarke B: Vitamin D insufficiency. Mayo Clin Proc 86: 50–60, 2011.
  • Tavafi M: Diabetic nephropathy and antioxidants. J Nephropathology 2:20–27, 2013.
  • Gheissari A, Mehrasa P, Merrikhi A, Madihi Y: Acute kidney injury: a pediatric experience over 10 years at a tertiary care center. J Nephropathol 1:101–08, 2012.
  • Zerwekh JE: Blood biomarkers of vitamin D status. Am J Clin Nutr 87:1087–1091, 2008.
  • Woerle HJ, Pimenta WP, Meyer C, Gosmanov NR, Szoke E, Szombathy T, Mitrakou A, Gerich JE: Diagnostic and therapeutic implications of relationships between fasting, 2-hour post challenge plasma glucose and hemoglobin A1c values. Arch Intern Med 164:1627–1632, 2004.
  • Pittas A, Sun Q, Manson J, Dawson-Hughes B, Hu F: Plasma 25-hydroxyvitamin D concentration and risk of incident type 2 diabetes in women. Diabetes Care 33:2021–2023, 2010.
  • Schöttker B, Herder C, Rothenbacher D, Perna L, Müller H, Brenner H: Serum 25-hydroxyvitamin D levels and incident diabetes mellitus type 2. a competing risk analysis in a large population-based cohort of older adults. Eur J Epidemiol 28:267–275, 2013.
  • Chiu K, Chu A, Go V, Saad M: Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 79:820–825, 2004.
  • Kayaniyil S, Harris S, Retnakaran R, Vieth R, Knight JA, Gerstein HC, Perkins BA, Zinman B, Hanley AJ: Prospective association of 25(OH)D with metabolic syndrome. Clin Endocrinol (Oxf) 80:502–507, 2014.
  • Lau, S, Gunton J, Athayde N, Byth K, Cheung N: Serum 25-hydroxyvitamin D and glycated hemoglobin levels in women with gestational diabetes mellitus. Med J 194:334–337, 2011.
  • Hurskainen A, Virtanen J, Tuomainen T, Nurmi T, Voutilainen S: Association of serum 25-hydroxyvitamin D with type 2 diabetes and markers of insulin resistance in a general older population in Finland. Diabetes Metab Res Rev 28:418–423, 2012.
  • Need A, O'Loughlin P, Horowitz M, Nordin B: Relationship between fasting serum glucose, age, body mass index and serum 25 hydroxyvitamin D in postmenopausal women. Clin Endocrinol (Oxford) 62:738–741, 2005.
  • Borissova A, Tankov, T, Kirilov G, Dakovska L, Kovacheva R: The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients. Int J Clin Pract 57:258–261, 2013.
  • Al-Daghri NM, Alkharfy KM, Al-Othman A, El-Kholie E, Moharram O, Alokail MS, Al-Saleh Y, Sabico S, Kumar S, Chrousos GP: Vitamin D supplementation as an adjuvant therapy for patients with T2DM: an 18-month prospective interventional study. Cardiovasc Diabetol 11:85, 2012.
  • Talaei A, Mohamadi M, Adgi Z: The effect of vitamin D on insulin resistance in patients with type 2 diabetes. Diabetol Metab Syndr 5:8, 2013.
  • Mitri J, Dawson-Hughes B, Hu F, Pittas A: Effects of vitamin D and calcium supplementation on pancreatic β cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: the calcium and vitamin D for diabetes mellitus (CaDDM) randomized controlled trial. Am J Clin Nutr 94:486–494, 2011.
  • Heaney R, French C, Nguyen S, Ferreira M, Baggerly LL, Brunel L, Veugelers P: A novel approach localizes the association of vitamin d status with insulin resistance to one region of the 25-hydroxyvitamin D continuum. Adv Nutr 4:303–310, 2013.
  • Heshmat R, Tabatabaei-Malazy O, Abbaszadeh-Ahranjani S, Shahbazi S, Khooshehchin G, Bandarian F, Larijani B: Effect of vitamin D on insulin resistance and anthropometric parameters in type 2 diabetes: a randomized double-blind clinical trial. Daru 20:10, 2012.
  • Breslavsky A, Frand J, Matas Z, Boaz M, Barnea, Z, Shargorodsky M: Effect of high doses of vitamin D on arterial properties, adiponectin, leptin and glucose homeostasis in type 2 diabetic patients. Clin Nutr 32:970–975, 2013.
  • Jorde R, Figenschau Y: Supplementation with cholecalciferol does not improve glycemic control in diabetic subjects with normal serum 25-hydroxyvitamin D levels. Eur J Nutr 48:349–354, 2009.
  • Witham MD, Dore FJ, Druburgh M, Sugden JA, Morris AD, Struthers AD: The effect of different doses of vitamin D3 on markers of vascular health. Diabetologia 53:2112–2119, 2010.
  • Jorde R, Grimnes G: Vitamin D and metabolic health with special reference to the effect of vitamin D on serum lipids. Prog Lipid Res 50:303–312, 2011.
  • Kazlauskaite R, Powell LH, Mandapakala C, Cursio JF, Avery EF, Calvin J: Vitamin D is associated with atheroprotective high density lipoprotein profile in postmenopausal women. J Clin Lipidol 4:113–119, 2010.
  • Querfeld U, Hoffmann MM, Klaus G, Eifinger F, Ackerschott M, Michalk D, Kern PA: Antagonistic effects of vitamin D and parathyroid hormone on lipoprotein lipase in cultured adipocytes. J Am Soc Nephrol 10:2158–2164, 1999.
  • Huang Y, Li X, Wang M, Ning H,   AL, Li Y, Sun C: Lipoprotein lipase links vitamin D, insulin resistance, and type 2 diabetes: a cross-sectional epidemiological study. Cardiovasc Diabetol 12:17, 2013.
  • Von Hurst PR, Stonehouse W, Coad J: Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand. Br J Nutr 28:1–7, 2009.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.